Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pyrdol, Jason"'
Autor:
Hu Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Leet DE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Allesøe RL; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Luoma AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Liu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Forman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Huang T; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Iorgulescu JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Holden R; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA., Sarkizova S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Gohil SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Academic Haematology, University College London, London, UK., Redd RA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Sun J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Elagina L; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Giobbie-Hurder A; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Zhang W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Peter L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Ciantra Z; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rodig S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Olive O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shetty K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pyrdol J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Uduman M; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lee PC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Bachireddy P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Yoon CH; Harvard Medical School, Boston, MA, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Neuberg D; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Pentelute BL; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Hacohen N; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Shukla SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Olsen LR; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.; Center for Genomic Medicine, Copenhagen University Hospital, Copenhagan, Denmark., Barouch DH; Harvard Medical School, Boston, MA, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Wucherpfennig KW; Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Fritsch EF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. patrick_ott@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. patrick_ott@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. patrick_ott@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. patrick_ott@dfci.harvard.edu.
Publikováno v:
Nature medicine [Nat Med] 2021 Mar; Vol. 27 (3), pp. 515-525. Date of Electronic Publication: 2021 Jan 21.
Autor:
Ferrari de Andrade L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts. kai_wucherpfennig@dfci.harvard.edu Lucas.FerrarideAndrade@mssm.edu.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Oncological Sciences and Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Kumar S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Luoma AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Ito Y; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Alves da Silva PH; Department of Oncological Sciences and Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Pan D; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Pyrdol JW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Yoon CH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts. kai_wucherpfennig@dfci.harvard.edu Lucas.FerrarideAndrade@mssm.edu.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2020 Jun; Vol. 8 (6), pp. 769-780. Date of Electronic Publication: 2020 Mar 24.
Autor:
de Andrade LF; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA.; Department of Oncological Sciences and Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lu Y; Department of Data Sciences and., Luoma A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA., Ito Y; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA., Pan D; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA., Pyrdol JW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Yoon CH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Yuan GC; Department of Data Sciences and.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
JCI insight [JCI Insight] 2019 Dec 05; Vol. 4 (23). Date of Electronic Publication: 2019 Dec 05.
Autor:
Ferrari de Andrade L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA., Tay RE; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA., Pan D; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA., Luoma AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA., Ito Y; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA., Badrinath S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA., Tsoucas D; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA., Franz B; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA., May KF Jr; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA., Harvey CJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA., Kobold S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA., Pyrdol JW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA., Yoon C; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.; Department of Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA., Yuan GC; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA., Dranoff G; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. kai_wucherpfennig@dfci.harvard.edu.; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2018 Mar 30; Vol. 359 (6383), pp. 1537-1542.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.